Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome (Q38374044)

2 September 2017

1 reference

title

Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome (English)

1 reference

acute disseminated encephalomyelitis

2 September 2017

1 reference

Diederik L H Koelman

1

1 reference

PubMed ID

25761377

2 September 2017

Farrah J Mateen

series ordinal

2

1 reference

2 September 2017

13 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

262

1 reference

2 September 2017

9

1 reference

2 September 2017

2013-2024

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-015-7694-7

2 September 2017

0 references

cites work

Non-MS recurrent demyelinating diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Incidence of acquired demyelination of the CNS in Canadian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

The spectrum of postinfectious encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in North Indian children: clinical profile and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Postinfectious neurologic syndromes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis: postinfectious, postimmunization and variant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in children and adolescents: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Teaching neuroimages: MRI time lag with acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Treatment of acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Postinfectious inflammatory disorders: subgroups based on prospective follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Multiphasic disseminated encephalomyelitis mimicking multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Defining encephalopathy in acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Isolated brain stem lesion in children: is it acute disseminated encephalomyelitis or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

A long-term follow-up study using IPMSSG criteria in children with CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis: a 10-year cohort study in Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

A comparison of MRI criteria for diagnosing pediatric ADEM and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7694-7

Acute disseminated encephalomyelitis

21 January 2018

1 reference

12 December 2020

Pediatric multiple sclerosis

1 reference

12 December 2020

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood

1 reference

12 December 2020

Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes

1 reference

12 December 2020

NEUROLOGICAL COMPLICATIONS OF SMALLPOX VACCINATION

1 reference

12 December 2020

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

1 reference

12 December 2020

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

12 December 2020

Pediatric demyelinating diseases

1 reference

12 December 2020

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.

1 reference

12 December 2020

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

1 reference

12 December 2020

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.

1 reference

12 December 2020

Role of MRI in the differentiation of ADEM from MS in children

1 reference

12 December 2020

CSF characteristics in early-onset multiple sclerosis

1 reference

12 December 2020

Acute fulminant demyelinating disease: a descriptive study of 60 patients

1 reference

12 December 2020

Prognostic factors after a first attack of inflammatory CNS demyelination in children

1 reference

12 December 2020

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

1 reference

12 December 2020

Deep gray matter involvement in children with acute disseminated encephalomyelitis.

1 reference

12 December 2020

The Role of Hyperergy in Measles Encephalitis

1 reference

12 December 2020

Multiple sclerosis and antecedent infections: a case-control study

1 reference

12 December 2020

Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children

1 reference

12 December 2020

Gadolinium enhancement in acute disseminated encephalomyelitis

1 reference

12 December 2020

10.1007/S00415-015-7694-7

Identifiers

DOI

1 reference

PubMed ID

25761377

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25761377